Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

YAN Jianwei. Clinical observation of levocarnitine in prevention from peripheral nerve toxicity caused by paclitaxel[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 372-373. doi: 10.3969/j.issn.1006-0111.2014.05.016
Citation: YAN Jianwei. Clinical observation of levocarnitine in prevention from peripheral nerve toxicity caused by paclitaxel[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 372-373. doi: 10.3969/j.issn.1006-0111.2014.05.016

Clinical observation of levocarnitine in prevention from peripheral nerve toxicity caused by paclitaxel

doi: 10.3969/j.issn.1006-0111.2014.05.016
  • Received Date: 2013-04-01
  • Rev Recd Date: 2013-07-30
  • Objective To observe levocarnitine in prevention and treatment of peripheral nerve toxicity caused by paclitaxel. Methods 64 cancer patients treated with paclitaxel-based chemotherapy were randomly divided into two groups, the preventive treatment group and control group.The patients in the preventive treatment group were treated with paclitaxel chemotherapy and levocarnitine.The patients in the control group were treated with the same chemotherapy but without levocarnitine.The incidence rate of neurotoxicity between two groups were compared. Results The incidence rate of neurotoxicity in the preventive treatment group was lower than that of the control group(P<0.05). Conclusion Application of levocarnitine in paclitaxel-based chemotherapy could reduce the neurotoxicity caused by chemotherapy.
  • [1] Ghirardi O,Lo Giudice P,Pisano C,et al.Acetyl-L-carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin,without altering its antitumor properties[J].Anticancer Res,2005,25(4):2681-2687.
    [2] Gunes D, Kirkim G, Kolatan E,et al. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity[J].Chemotherapy,2011,57(3):186-194.
    [3] 孙 燕.抗癌药物急性与亚急性毒性反应分度标准临床肿瘤手册[M].5版.北京:人民卫生出版社,2005:145.
    [4] Xiao WH, Zheng H, Zheng FY,et al. Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat[J].Neuroscience,2011,199:461-469.
    [5] He MD, Xu SC, Lu YH,et al.L-carnitine protects against nickel-induced neurotoxicity by maintaining mitochondrial function in neuro-2a cells[J].Toxicol Appl Pharmacol,2011,253(1):38-44.
    [6] Nagesh BG, Kumar A, Singh RL.Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function[J].Neurotox Res,2011,19(2):319-329.
    [7] Zheng H, Xiao WH, Bennett GJ. Functional deficits in peripheral nerve mitochondria in rats with paclitaxel-and oxaliplatin-evoked painfulperipheral neuropathy[J]. Exp Neurol,2011,232(2):154-161.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2375) PDF downloads(167) Cited by()

Related
Proportional views

Clinical observation of levocarnitine in prevention from peripheral nerve toxicity caused by paclitaxel

doi: 10.3969/j.issn.1006-0111.2014.05.016

Abstract: Objective To observe levocarnitine in prevention and treatment of peripheral nerve toxicity caused by paclitaxel. Methods 64 cancer patients treated with paclitaxel-based chemotherapy were randomly divided into two groups, the preventive treatment group and control group.The patients in the preventive treatment group were treated with paclitaxel chemotherapy and levocarnitine.The patients in the control group were treated with the same chemotherapy but without levocarnitine.The incidence rate of neurotoxicity between two groups were compared. Results The incidence rate of neurotoxicity in the preventive treatment group was lower than that of the control group(P<0.05). Conclusion Application of levocarnitine in paclitaxel-based chemotherapy could reduce the neurotoxicity caused by chemotherapy.

YAN Jianwei. Clinical observation of levocarnitine in prevention from peripheral nerve toxicity caused by paclitaxel[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 372-373. doi: 10.3969/j.issn.1006-0111.2014.05.016
Citation: YAN Jianwei. Clinical observation of levocarnitine in prevention from peripheral nerve toxicity caused by paclitaxel[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 372-373. doi: 10.3969/j.issn.1006-0111.2014.05.016
Reference (7)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return